Skip to content

Can-Fite BioPharma Ltd.

CANF

CIK 0001536196 · Pharmaceutical Preparations · NYSE

← back to feed
Revenue (TTM)
$405K
−39.9% YoY FY Dec 2025
Net Income (TTM)
−$9.83M
−24.7% YoY FY Dec 2025
EPS Diluted (TTM)
−$5.97
+45.0% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
-2,456.8%
FY Dec 2025
Net Margin
-2,426.7%
FY Dec 2025
Free Cash Flow (TTM)
−$8.95M
FY Dec 2025
Cash
$5.53M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
2.62M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings